Stay updated on Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial

Sign up to get notified when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating an update in the clinical efficacy and safety assessment of the 13-valent pneumococcal conjugate vaccine in multiple myeloma patients treated with novel agents.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:12.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' The new description provides examples of eligibility criteria, such as a person's general health condition or prior treatments, and includes specific inclusion and exclusion criteria for the study.
    Difference
    10%
    Check dated 2024-05-22T21:28:36.000Z thumbnail image
  7. Check
    38 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T21:52:31.000Z thumbnail image

Stay in the know with updates to Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.